Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND hCG AND Treatment
13 results:

  • 1. [Clinicopathological analysis of lung metastatic tumor].
    Lou N; Niu YR; Yang F; Lu ZH
    Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1039-1044. PubMed ID: 34496496
    [No Abstract]    [Full Text] [Related]  

  • 2. Elevated beta human chorionic gonadotropin in a non-pregnant female diagnosed with anal squamous cell carcinoma.
    Pokharel K; Gilbar PJ; Mansfield SK; Nair LM; So A
    J Oncol Pharm Pract; 2020 Jul; 26(5):1266-1269. PubMed ID: 31840564
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A rare case of primary rectal choriocarcinoma and review of the literature.
    Telli TA; Demircan NC; Alan O; Tuylu TB; Arikan R; Ercelep O; Atıcı AE; Ergelen R; Seven IE; Babacan NA; Kaya S; Dane F; Fulden Yumuk P
    J Oncol Pharm Pract; 2020 Jun; 26(4):989-994. PubMed ID: 31547751
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Correlation of IGFBP-6 expression with apoptosis and migration of colorectal carcinoma cells.
    Qiu F; Gao W; Wang B
    Cancer Biomark; 2018; 21(4):893-898. PubMed ID: 29439316
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Gonadotropin and tumorigenesis: Direct and indirect effects on inflammatory and immunosuppressive mediators and invasion.
    Khare P; Bose A; Singh P; Singh S; Javed S; Jain SK; Singh O; Pal R
    Mol Carcinog; 2017 Feb; 56(2):359-370. PubMed ID: 27152491
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Immunoassay of nine serological tumor markers on hydrogel-based microchip].
    Zubcova ZhI; Savvateeva EN; Butvilovskaia VI; Cybul'skaia MV; Chechetkin VR; Samokhina LO; Vinnitskiĭ LI; Maslennikov VV; Reznikov IuP; Zasedatelev AS; Rubina AIu
    Bioorg Khim; 2013; 39(6):693-704. PubMed ID: 25696931
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A personalized approach to cancer treatment: how biomarkers can help.
    Duffy MJ; Crown J
    Clin Chem; 2008 Nov; 54(11):1770-9. PubMed ID: 18801934
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A noninvasive approach for assessing tumor hypoxia in xenografts: developing a urinary marker for hypoxia.
    Nelson DW; Cao H; Zhu Y; Sunar-Reeder B; Choi CY; Faix JD; Brown JM; Koong AC; Giaccia AJ; Le QT
    Cancer Res; 2005 Jul; 65(14):6151-8. PubMed ID: 16024616
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Trophoblastic tissue spread to the sigmoid colon after uterine perforation.
    Levin I; Grisaru D; Pauzner D; Almog B
    Obstet Gynecol; 2004 Nov; 104(5 Pt 2):1172-4. PubMed ID: 15516441
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Monoclonal antibodies to two epitopes of beta-human chorionic gonadotropin for the treatment of cancer.
    Iversen PL; Mourich DV; Moulton HM
    Curr Opin Mol Ther; 2003 Apr; 5(2):156-60. PubMed ID: 12772505
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Doctor's dilemma: incorporating tumor markers into clinical decision-making.
    Canil CM; Tannock IF
    Semin Oncol; 2002 Jun; 29(3):286-93. PubMed ID: 12063682
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The prognostic value of CEA, beta hcg, AFP, CA125, CA19-9 and C-erb B-2, beta hcg immunohistochemistry in advanced colorectal cancer.
    Webb A; Scott-Mackie P; Cunningham D; Norman A; Andreyev J; O'Brien M; Bensted J
    Ann Oncol; 1995 Jul; 6(6):581-7. PubMed ID: 8573538
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.